EP1210088A4 - 2-aminobenzoxazinone zur behandlung des herpes simplex virus - Google Patents
2-aminobenzoxazinone zur behandlung des herpes simplex virusInfo
- Publication number
- EP1210088A4 EP1210088A4 EP00948615A EP00948615A EP1210088A4 EP 1210088 A4 EP1210088 A4 EP 1210088A4 EP 00948615 A EP00948615 A EP 00948615A EP 00948615 A EP00948615 A EP 00948615A EP 1210088 A4 EP1210088 A4 EP 1210088A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- benzoxazinones
- amino
- treatment
- herpes simplex
- simplex virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- MCDXWLAYOXBQBG-UHFFFAOYSA-N 2-amino-4h-1,2-benzoxazin-3-one Chemical class C1=CC=C2CC(=O)N(N)OC2=C1 MCDXWLAYOXBQBG-UHFFFAOYSA-N 0.000 title 1
- 241000700584 Simplexvirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14295699P | 1999-07-12 | 1999-07-12 | |
| US142956P | 1999-07-12 | ||
| PCT/US2000/018817 WO2001003697A1 (en) | 1999-07-12 | 2000-07-11 | 2-amino-benzoxazinones for the treatment of herpes simplex virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1210088A1 EP1210088A1 (de) | 2002-06-05 |
| EP1210088A4 true EP1210088A4 (de) | 2003-03-12 |
Family
ID=22501956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00948615A Withdrawn EP1210088A4 (de) | 1999-07-12 | 2000-07-11 | 2-aminobenzoxazinone zur behandlung des herpes simplex virus |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1210088A4 (de) |
| JP (1) | JP2003504334A (de) |
| KR (1) | KR20020046273A (de) |
| CN (1) | CN1481245A (de) |
| AU (2) | AU774370B2 (de) |
| BR (1) | BR0012380A (de) |
| CA (1) | CA2378014A1 (de) |
| HK (1) | HK1046862A1 (de) |
| MX (1) | MXPA02000485A (de) |
| WO (1) | WO2001003697A1 (de) |
| ZA (1) | ZA200200311B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009002960A (es) * | 2006-09-21 | 2009-06-26 | Activx Biosciences Inc | Inhibidores de serina hidrolasa. |
| EP4144336A1 (de) * | 2021-05-14 | 2023-03-08 | The Procter & Gamble Company | Feuchttücher mit einem cellulosesubstrat und einer sanften lotion |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996037485A1 (en) * | 1995-05-24 | 1996-11-28 | G.D. Searle & Co. | 2-amino-benzoxazinones for the treatment of viral infections |
-
2000
- 2000-07-11 CN CNA008164517A patent/CN1481245A/zh active Pending
- 2000-07-11 JP JP2001508977A patent/JP2003504334A/ja not_active Withdrawn
- 2000-07-11 EP EP00948615A patent/EP1210088A4/de not_active Withdrawn
- 2000-07-11 BR BR0012380-3A patent/BR0012380A/pt not_active IP Right Cessation
- 2000-07-11 CA CA002378014A patent/CA2378014A1/en not_active Abandoned
- 2000-07-11 HK HK02108474.6A patent/HK1046862A1/zh unknown
- 2000-07-11 AU AU62089/00A patent/AU774370B2/en not_active Ceased
- 2000-07-11 MX MXPA02000485A patent/MXPA02000485A/es unknown
- 2000-07-11 WO PCT/US2000/018817 patent/WO2001003697A1/en not_active Ceased
- 2000-11-07 KR KR1020027000487A patent/KR20020046273A/ko not_active Ceased
-
2002
- 2002-01-14 ZA ZA200200311A patent/ZA200200311B/xx unknown
-
2004
- 2004-08-13 AU AU2004203884A patent/AU2004203884A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996037485A1 (en) * | 1995-05-24 | 1996-11-28 | G.D. Searle & Co. | 2-amino-benzoxazinones for the treatment of viral infections |
Non-Patent Citations (3)
| Title |
|---|
| ABOOD, NORMAN A. ET AL: "Inhibition of human cytomegalovirus protease by benzoxazinones and evidence of antiviral activity in cell culture", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (1997), 7(16), 2105-2108, XP004136393 * |
| PARLOW, JOHN J. ET AL: "Solution-phase parallel synthesis of a benzoxazinone library using complementary molecular reactivity and molecular recognition (CMR/R) purification technology", TETRAHEDRON (1998), 54(16), 4013-4031, XP004162177 * |
| See also references of WO0103697A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1481245A (zh) | 2004-03-10 |
| HK1046862A1 (zh) | 2003-01-30 |
| KR20020046273A (ko) | 2002-06-20 |
| AU774370B2 (en) | 2004-06-24 |
| EP1210088A1 (de) | 2002-06-05 |
| AU2004203884A1 (en) | 2004-09-09 |
| MXPA02000485A (es) | 2004-09-10 |
| AU6208900A (en) | 2001-01-30 |
| BR0012380A (pt) | 2002-08-27 |
| ZA200200311B (en) | 2003-01-14 |
| JP2003504334A (ja) | 2003-02-04 |
| CA2378014A1 (en) | 2001-01-18 |
| WO2001003697A1 (en) | 2001-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL129352A0 (en) | Benzimidazole-2- carbamates for the treatment of viral infections and cancer | |
| AP9801414A0 (en) | Combination effective for the treatment of impotence | |
| IL148579A0 (en) | Oncolytic combinations for the treatment of cancer | |
| GB9709360D0 (en) | Methods for the treatment of herpes virus infections | |
| GB9930570D0 (en) | Therapy | |
| GB9907243D0 (en) | Therapy | |
| ZA973622B (en) | Use of forms of hyaluronic acid (HA) for the treatment of cancer. | |
| AU2001260834A1 (en) | The treatment of herpes | |
| PL356640A1 (en) | Treatment of viral infections using levovirintm | |
| AP2002002432A0 (en) | Treatment of viral infections | |
| HUP0100365A3 (en) | Combination therapy for the treatment of aids | |
| ZA200200311B (en) | 2-amino-benzoxazinones for the treatment of herpes simplex virus. | |
| MXPA03004454A (es) | Derivados de imidazolona para el tratamiento de enfermedades virales. | |
| AU6896300A (en) | Vaccines for the treatment of autoimmune disease | |
| AU7070700A (en) | Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry | |
| SI1220858T1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
| GB9821668D0 (en) | A novel treatment for herpes simplex virus infections | |
| GB9710794D0 (en) | A novel treatment for herpes simplex virus infections | |
| GB9816353D0 (en) | The treatment of viral disorders | |
| GB9816355D0 (en) | The treatment of viral disorders | |
| GB9900428D0 (en) | Virus inactivation process | |
| ZA9810306B (en) | Combination therapy for the treatment of aids | |
| IL149443A0 (en) | Compositions for treating viral diseases | |
| HK1023722A (en) | Benzimidazole-2-carbamates for the treatment of viral infections and cancer | |
| AU7157598A (en) | Method for the treatment of viral disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020201 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20030129 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07D 413/12 B Ipc: 7C 07D 265/24 B Ipc: 7A 61P 31/12 B Ipc: 7C 07D 413/04 B Ipc: 7A 61K 31/536 A |
|
| 17Q | First examination report despatched |
Effective date: 20030502 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20070201 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1046862 Country of ref document: HK |